IL327017A - שיטות לטיפול במחלות ומצבים הקשורים לחילוף חומרים של שומנים וכולסטרול - Google Patents
שיטות לטיפול במחלות ומצבים הקשורים לחילוף חומרים של שומנים וכולסטרולInfo
- Publication number
- IL327017A IL327017A IL327017A IL32701726A IL327017A IL 327017 A IL327017 A IL 327017A IL 327017 A IL327017 A IL 327017A IL 32701726 A IL32701726 A IL 32701726A IL 327017 A IL327017 A IL 327017A
- Authority
- IL
- Israel
- Prior art keywords
- acid
- microbial
- composition
- disease
- metabolism
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363581550P | 2023-09-08 | 2023-09-08 | |
| PCT/US2024/044061 WO2025054048A1 (en) | 2023-09-08 | 2024-08-27 | Methods and uses of microbiome compositions, components, or metabolites for treating lipid and cholesterol metabolism associated diseases, disorders, and conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL327017A true IL327017A (he) | 2026-05-01 |
Family
ID=94924513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL327017A IL327017A (he) | 2023-09-08 | 2024-08-27 | שיטות לטיפול במחלות ומצבים הקשורים לחילוף חומרים של שומנים וכולסטרול |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4774366A1 (he) |
| CN (1) | CN122318990A (he) |
| AU (1) | AU2024338317A1 (he) |
| IL (1) | IL327017A (he) |
| WO (1) | WO2025054048A1 (he) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3059453A1 (en) * | 2017-04-11 | 2018-10-18 | Servatus Ltd | Methods for the treatment of inflammation and inflammatory conditions |
| CN110721203A (zh) * | 2018-07-17 | 2020-01-24 | 深圳爱米基因科技有限责任公司 | 双歧杆菌与黄连素联用对糖尿病前期和2型糖尿病的作用 |
-
2024
- 2024-08-27 IL IL327017A patent/IL327017A/he unknown
- 2024-08-27 AU AU2024338317A patent/AU2024338317A1/en active Pending
- 2024-08-27 CN CN202480070776.2A patent/CN122318990A/zh active Pending
- 2024-08-27 WO PCT/US2024/044061 patent/WO2025054048A1/en not_active Ceased
- 2024-08-27 EP EP24863449.5A patent/EP4774366A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025054048A1 (en) | 2025-03-13 |
| EP4774366A1 (en) | 2026-07-15 |
| AU2024338317A1 (en) | 2026-04-23 |
| CN122318990A (zh) | 2026-06-30 |
| WO2025054048A9 (en) | 2025-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL205323A0 (en) | Anti - pcsk9 and methods for treating lipid and cholesterol disorders | |
| CA3304156A1 (en) | Methods for treating lipid and cholesterol metabolism associated diseases and conditions | |
| EP4155413A4 (en) | METHOD AND KIT FOR QUANTIFYING LIPOPROTEIN CHOLESTEROL | |
| GB202214972D0 (en) | Products and methods for use in treating NDP-related diseases | |
| IL326065A (he) | שיטות לטיפול במצבים רפואיים ומחלות | |
| GB2633904B (en) | Display panel and method for fabricating display panel | |
| GB202412689D0 (en) | Products and methods for treating autoimmine disease | |
| CA3299551A1 (en) | Methods for treating conditions and diseases | |
| AU2024900640A0 (en) | Treatment methods for muscle-associated diseases | |
| IL317115A (he) | שיטות לזיהוי וטיפול במחלות | |
| AU2023900188A0 (en) | Methods and agents for treating respiratory inflammation and associated diseases and conditions | |
| GB202215123D0 (en) | Affective gaming system and method | |
| GB202215114D0 (en) | Affective gaming system and method | |
| HK40118740A (en) | Methods for identifying and treating diseases | |
| RASULJON | LIPID PEROXIDATION PRODUCTS AND FREE FATTY ACIDS IN BLOOD PLASMA AND CEREBRAL SPINAL FLUID IN CHILDREN WITH CONVULSIVE SYNDROME | |
| CA3278848A1 (en) | Agents and methods for treating complement diseases | |
| HK40105936A (en) | Methods for reducing liver fat and for treating fatty liver disorders | |
| GB202417164D0 (en) | Method for identifying patients | |
| AU2021903721A0 (en) | Method for Treating Cyclophilin B Associated Diseases | |
| AU2021903724A0 (en) | Method for Treating Cyclophilin D Associated Diseases | |
| GB202404412D0 (en) | Products and methods for treating autoimmune diseases | |
| GB202414148D0 (en) | Products and method for treating autoimmune diseases | |
| AU2022900798A0 (en) | Inhibitors and methods for treating neurological diseases | |
| AU2024902352A0 (en) | Antisense treatment for metabolic diseases | |
| HK40118639A (en) | Method of treating progressive heart failure in subjects at high risk of poor outcomes |